These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35477950)

  • 21. Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection.
    Gopalakrishnan V; Bose E; Nair U; Cheng Y; Ghebremichael M
    BMC Infect Dis; 2020 Oct; 20(1):756. PubMed ID: 33059622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana.
    Obiri-Yeboah D; Pappoe F; Baidoo I; Arthur F; Hayfron-Benjamin A; Essien-Baidoo S; Kwakye-Nuako G; Ayisi Addo S
    BMC Infect Dis; 2018 May; 18(1):230. PubMed ID: 29783953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to planned treatment interruptions in HIV infection varies across childhood.
    Paediatric European Network for Treatment of AIDS
    AIDS; 2010 Jan; 24(2):231-41. PubMed ID: 20010073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
    Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
    PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
    Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.
    Majekodunmi AO; Thorne C; Malyuta R; Volokha A; Callard RE; Klein NJ; Lewis J;
    Pediatr Infect Dis J; 2017 May; 36(5):e123-e129. PubMed ID: 28403051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old.
    Siegfried N; Davies MA; Penazzato M; Muhe LM; Egger M
    Cochrane Database Syst Rev; 2013 Oct; 10(10):CD010309. PubMed ID: 24114324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multilevel model on longitudinal data analysis in determinants of CD4 cell count among antiretroviral therapy attendant of HIV infected adults follow up in Gondar Teaching Referral Hospital, Gonder, Ethiopia.
    Kebede K
    AIDS Res Ther; 2021 Jan; 18(1):5. PubMed ID: 33451347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia.
    Ebissa G; Deyessa N; Biadgilign S
    AIDS Care; 2015; 27(6):723-30. PubMed ID: 25599414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15.
    Gesesew HA; Ward P; Woldemichael K; Mwanri L
    PLoS One; 2018; 13(6):e0198815. PubMed ID: 29912974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of poor CD4 and weight recovery in HIV-infected children initiating ART in South Africa.
    Zanoni BC; Phungula T; Zanoni HM; France H; Cook EF; Feeney ME
    PLoS One; 2012; 7(3):e33611. PubMed ID: 22438965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on the mortality and risk factors among HIV/AIDS patients receiving antiretroviral therapy in Xinjiang Uygur Autonomous Region].
    Ni M; Chen X; Hu X; Ma Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):953-8. PubMed ID: 25582364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children.
    Desmonde S; Dicko F; Koueta F; Eboua T; Balestre E; Amani-Bosse C; Aka EA; Lawson-Evi K; Amorissani-Folquet M; Kouakou K; Koumakpai S; Renner L; Signaté Sy H; Leroy V;
    AIDS; 2014 Jul; 28(11):1645-55. PubMed ID: 24804858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ gain percentile curves for monitoring response to antiretroviral therapy in HIV-infected adults.
    Yotebieng M; Maskew M; Van Rie A
    AIDS; 2015 Jun; 29(9):1067-75. PubMed ID: 26125140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term virological outcome in children receiving first-line antiretroviral therapy.
    Chandrasekaran P; Shet A; Srinivasan R; Sanjeeva GN; Subramanyan S; Sunderesan S; Ramesh K; Gopalan B; Suresh E; Poornagangadevi N; Hanna LE; Chandrasekar C; Wanke C; Swaminathan S
    AIDS Res Ther; 2018 Nov; 15(1):23. PubMed ID: 30477526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.
    Koethe JR; Jenkins CA; Shepherd BE; Stinnette SE; Sterling TR
    Clin Infect Dis; 2011 Nov; 53(9):952-60. PubMed ID: 21946189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of suboptimal immune recovery among a Chinese Yi ethnicity population with sustained HIV suppression.
    Chen L; Liu CH; Kang S; Du L; Ma F; Li C; Bai L; Li H; Tang H
    BMC Infect Dis; 2022 Feb; 22(1):137. PubMed ID: 35135485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.
    Wood E; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV; Montaner JS
    Ann Intern Med; 2003 Nov; 139(10):810-6. PubMed ID: 14623618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children.
    HIV Paediatric Prognostic Markers Collaborative Study
    AIDS; 2006 Jun; 20(9):1289-94. PubMed ID: 16816558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.